Search results
Results From The WOW.Com Content Network
This is a shortened version of the sixth chapter of the ICD-9: Diseases of the Nervous System and Sense Organs. It covers ICD codes 320 to 389. The full chapter can be found on pages 215 to 258 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1.
Multiple system atrophy (MSA) is a rare neurodegenerative disorder [1] characterized by tremors, slow movement, muscle rigidity, postural instability (collectively known as parkinsonism), autonomic dysfunction and ataxia.
ICD-9-CM ICD-10-CM Hypokinetic Movement disorders Poliomyelitis, [6] acute 045 A80 Amyotrophic lateral sclerosis, ALS [6] (Lou Gehrig's disease) 335.20 G12.21 Parkinson's disease (Primary or Idiopathic Parkinsonism) 332 G20 Secondary Parkinsonism: G21 Parkinson plus syndromes: Pantothenate kinase-associated neurodegeneration: G23.0
ICD-10-PCS: 00H00MZ: OPS-301 code ... movement disorders such as Parkinson's disease, tremor and dystonia and other neuropsychiatric ... epilepsy with rates of 8–25 ...
Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia (slowed movements), rigidity, and postural instability. [ 1 ] [ 2 ] Both hypokinetic (bradykinesia and akinesia) as well as hyperkinetic (cogwheel rigidity and tremors at rest) features are displayed by Parkinsonism. [ 3 ]
Generally, diseases outlined within the ICD-10 codes G20-G26 within Chapter VI: Diseases of the nervous system should be included in this category. Wikimedia Commons has media related to Extrapyramidal and movement disorders .
The four cardinal motor symptoms of Parkinson's—bradykinesia (slowed movements), postural instability, rigidity, and tremor—are called parkinsonism. [ 9 ] [ 10 ] These four symptoms are not exclusive to Parkinson's and can occur in many other conditions, [ 11 ] [ 12 ] including HIV infection and recreational drug use .
Parkinson-plus syndromes are usually more rapidly progressive and less likely to respond to antiparkinsonian medication than PD. [10] [11] However, the additional features of the diseases may respond to medications not used in PD. [citation needed] Current therapy for Parkinson-plus syndromes is centered around a multidisciplinary treatment of ...